Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


LigoCyte Pharmaceuticals Inc.

Division of Takeda Pharmaceutical Co. Ltd.

Latest From LigoCyte Pharmaceuticals Inc.

Takeda Leads Uncluttered Race For First Norovirus Therapy

Although norovirus infections are implicated in roughly 200,000 deaths per year, there are only four candidates in clinical development, Datamonitor Healthcare notes. This may be due partly to challenges posed by the virus' strain diversity and a lack of epidemiologic data.

Infectious Diseases BioPharmaceutical

Takeda Gains On Sanofi As Two-Shot Dengue Vaccine Advances

While Sanofi late last year became the first company to commercialize a vaccine for dengue, Takeda has strengthened its position as the likely next to market contender following the start of a global Phase III program for its rival product.

Research & Development Infectious Diseases

Takeda Cements Norovirus Lead Through Vaccine Trial Start

Takeda has initiated dosing in the first field trial globally with a candidate vaccine for norovirus, maintaining its clear development lead in the area.

BioPharmaceutical United States

U.S. Site Closures As Takeda Restructures Vaccines Business

A fundamental restructuring of Takeda's vaccines operations will see the closure of three sites in the U.S. as it consolidates operations in this market in the Boston area as part of a revised global network for the unit.

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Gastrointestinal
  • Infectious & Viral Diseases
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Donald P Beeman , CEO
    Larry W Mikkola, Dir., Fin.
    Robert R Goodwin, PhD, Pres. & COO
    Charles E Richardson, PhD, EVP, R&D
    Robert F Bargatze, PhD, EVP, CSO
  • Contact Info
  • LigoCyte Pharmaceuticals Inc.
    Phone: (406) 585-2733
    2155 Analysis Dr.
    Bozeman, MT 59718